Showing results (31-40 of 214) with videos related to

Sort By:
Pageof 22
The Cochrane Database of Systematic Reviews|July 23, 2008
Drugs for treating urinary schistosomiasisAnthony Danso-Appiah, Jürg Utzinger, Jianping Liu, et al.
The Lancet Regional Health. Southeast Asia|January 27, 2025
Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'Md Zakiul Hassan, Amanda Rojek, Piero Olliaro, et al.
BMJ Global Health|March 19, 2026
Visceral leishmaniasis elimination in South Asia: lessons learnt can inform disease elimination in East AfricaPiero Olliaro, Dinesh Mondal, Ermias Diro, et al.
Malaria Journal|March 3, 2007
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in ColombiaLyda Osorio, Iveth Gonzalez, Piero Olliaro, et al.
Tropical Medicine & International Health : TM & IH|March 11, 2018
Eligibility criteria and outcome measures adopted in clinical trials of treatments of cutaneous leishmaniasis: systematic literature review covering the period 1991-2015Liliana López-Carvajal, Iván Vélez, María Patricia Arbeláez, et al.
Trials|May 30, 2021
Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrationsLakshmi Manoharan, Piero Olliaro, Peter W Horby, et al.
The American Journal of Tropical Medicine and Hygiene|November 21, 2019
Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets LawEugenia Olliaro, Piero Olliaro, Calvin W L Ho, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2015
Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and in vitro assaysSilvia Parapini, Piero Olliaro, Visweswaran Navaratnam, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
Artemisinin-based combination therapy for treating uncomplicated malariaDavid Sinclair, Babalwa Zani, Sarah Donegan, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sicknessMarcel Kaiser, Michael A Bray, Monica Cal, et al.
Pageof 22